Esperion Therapeutics, Inc. (ESPR)
2.605
-0.10
(-3.52%)
USD |
NASDAQ |
Mar 11, 15:48
Esperion Therapeutics Shareholders Equity (Quarterly) : -301.96M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Harrow, Inc. | 52.45M |
| Catalyst Pharmaceuticals, Inc. | 954.27M |
| Nektar Therapeutics | 85.09M |
| Rigel Pharmaceuticals, Inc. | 391.48M |
| AnaptysBio, Inc. | 37.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 465.89M |
| Debt to Equity Ratio | -1.806 |
| Current Ratio | 1.004 |
| Net Debt Paydown Yield | 0.32% |